Nobivac®

Feline 2-FeLV

The only vaccine with proven two-year duration of immunity for feline leukemia.

FELINE 2-FELV PROVIDES PROTECTION AGAINST FELINE LEUKEMIA

Feline Leukemia Virus (inactivated virus).

  • The only feline leukemia virus vaccine shown to be effective against persistent viremia for 2 years after vaccination.64
  • Superior Efficacy demonstrated vs. multiple FeLV vaccines65,66
    • The ONLY USDA-licensed 2-Year Duration of Immunity (DOI) FeLV vaccine (Ideal for adherence to AAFP guidelines)1,64,67
    • The ONLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real life conditions1
  • Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses1
  • Available in combination with other Nobivac feline vaccines to provide broader disease protection
  • Optimal choice for all cats under 1 year of age and healthy indoor/outdoor cats of any age

INDICATIONS:

Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline leukemia viruses. Duration of immunity is at least 2 years.

Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.

Efficacy & Comparisons

COMPARATIVE STUDY

EFFICACY & COMPARISONS

EFFICACY NOBIVAC® FELINE 2-FELV VERSUS PUREVAX® FELV

FIELD STUDY

No items to show.

Loading…

FELINE 2-FELV IS A SAFE CHOICE

  • 99.99% reaction-free in ongoing surveillance involving millions of doses1
  • Two-year duration of immunity means fewer vaccinations

ADMINISTRATION AND DOSAGE

  • Subcutaneous or intramuscular injection
  • Initial 1 mL dose administered at 9 weeks of age or older
  • Second 1 mL dose administered 3 to 4 weeks later
  • Revaccination every 2 years with a single dose is recommended
  • Available in a 25 x 1 mL dose presentation

ALSO AVAILABLE IN OTHER FORMULATIONS

DISEASE INFORMATION

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

Feline Leukemia Virus

Brochure

Educate your clients about FeLV with this easy to share brochure.

Download

Feline Sarcomas – What Do We Really Know

Guide

Feline Sarcomas – What Do We Really Know

Download

Feline Vaccination Guide

Brochure

A guide to help your pet parents understand common canine diseases and the importance of customizing vaccination for their pet’s unique lifestyle.

Download

No items to show.

Loading…

References:

1. Data on file, Merck Animal Health. 

64. Jirjis FF, Davis T, Lane J, et al. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine. Vet Ther. 2010;11(2):E1–E6. 

65. Torres AN, O’Halloran KP, Larson LJ, Schultz RD, Hoover EA. Feline leukemia virus immunity induced by whole inactivated virus vaccination. Vet Immunol Immunopathol. 2010; 134 (1–2):122–131. 

66. Patel M, Carritt K, Lane J, Jayappa H, Stahl M, Bourgeois M. Comparative efficacy of feline leukemia virus inactivated whole virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression. Clin Vaccine Immunol. 2015. 

67. American Association of Feline Practitioners. AAFP 2013 feline vaccination advisory panel report. J Feline Med Surgery. 2013; 15:785-808. 

71. Hines DL, Cutting JA, Dietrich DA, Walsh JA. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection. J Am Vet Med Assoc. 1991;199(10):1428-1430. 

74. Patel M, Carritt K, Lane J, Jayappa H, Stahl M. Comparative efficacy of feline leukemia virus inactivated whole virus vaccine and canarypox virus-vectored vaccine by modern molecular assays and conventional parameters. J Vet Intern Med. 2014;28:1060-1061.

View All Nobivac References